Pirkko-Liisa Kellokumpu-Lehtinen

3PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMidwifery not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 12, 2022
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.

Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen

|Jan 12, 2022
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer.

Sherene Loi, Roberto Salgado, Sylvia Adams

|Mar 15, 2018
p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial.

Jeff Sperinde, Weidong Huang, Aki Vehtari

Pageof 1